why choose us

First received: November 03, 2022

Clinical Trial: A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Moderate Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Single-dose, Pharmacokinetic Study of Mitapivat in Subjects With Moderate Hepatic Impairment Compared to Matched Healthy Control Subjects With Normal Hepatic Function

Brief Summary: The primary purpose of this study is to compare the pharmacokinetics (PK) of a single oral dose of mitapivat in participants with moderate hepatic impairment to that in matched healthy control participants with normal hepatic function.

Read more